Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Gichuhi, Stephen ^a   Irlam, James H ^b  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ARTIFICIAL TEAR; CIDOFOVIR; FLUOROURACIL; MITOMYCIN;

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; CONJUNCTIVA TUMOR; CRYOTHERAPY; DISEASE CONTROL; EYE SURGERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; HIV INFECTIONS; HUMANS;

EID: 84875539191     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005643.pub3     Document Type: Review

References (60)

1. Adjuvant topical 5fluorouracil (5FU) for ocular surface squamous neoplasia. Ongoing study 23/8/2012.
2. Aoki S, Kubo E, Nakamura S, Tsuzuki A, Tsuzuki S, Takahashi Y, et al.Possible prognostic markers in conjunctival dysplasia and squamous cell carcinoma. Japanese Journal of Ophthalmology 1998;42(4):256-61.
3. Ateenyi-Agaba C. Conjunctival squamous cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 1995;345(8951):695-6.
4. Ateenyi-Agaba C, Dai M, Le Calvez F, Katongole-Mbidde E, Smet A, Tommasino M, et al.TP53 mutations in squamous cell carcinomas of the conjuntiva: evidence for UV-induced mutagenesis. Mutagenesis 2004;19(5):399-401.
5. Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, Arsian A, Othieno E, Binta-Kahwa J, van Doorn LJ, Kleter B, Weiderpass E. Human papillomavirus infection and squamous cell carcinoma of the conjunctiva. British Journal of Cancer 2010;102:262-7.
6. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al.Grading quality of evidence and strengths of recommendations. BMJ 2004;328(7454):1490-7.
7. Barbazetto IA, Lee TC, Abramson DH. Treatment of conjunctival squamous cell carcinoma with photodynamic therapy. American Journal of Ophthalmology 2004;138(2):183-9.
8. Basti S, Macsai MS. Ocular surface squamous neoplasia: a review. Cornea 2003;22(7):687-704.
9. Bonanno A, Esmaeli B, Fingere MC, Nelson DV, Randal S, Weber RS. Social challenges of cancer patients with orbitofacial disfigurement. Ophthalmic Plastic and Reconstructive Surgery 2010;26:18-22.
10. Cartsburg O, Kallen C, Hillenkamp J, Sundmacher R, Pomjanski N, Bocking A. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. Analytical Cellular Pathology 2001;23(2):65-74.
11. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part three - photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagnosis and Photodynamic Therapy 2005;2(2):91-106.
12. Cerezo L, Otero J, Aragon G, Polo E, de la Torre A, Valcarcel F, et al.Conjunctival intraepithelial and invasive squamous cell carcinomas treated with strontium-90. Radiotherapy and oncology Journal of the European Society for Therapeutic Radiology and Oncology 1990;17(3):191-7.
13. Cervantes G, Rodriguez AA Jr, Leal AG. Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases. Canadian Journal of Ophthalmology 2002;37(1):14-9.
14. Chisi SK, Kollmann MKH, Karimurio J. Conjunctival squamous cell carcinoma in patients with Human Immunodeficiency Virus infection seen at two hospitals in Kenya. East African Medical Journal 2006;83(5):267-70.
15. Chu T, Sartorelli AC. Cancer chemotherapy. In: Katzung BG editor(s). Basic and clinical pharmacology. 9th Edition. Boston: McGraw Hill, 2004:898-930.
16. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJF, Vaccarella S, et al.Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366(9490):991-8.
17. Copeland RA. Limbal autograft for reconstruction after conjunctival squamous cell carcinoma. American Journal of Ophthalmology 1990;4(110):412-5.
18. de Koning MN, Waddell K, Magyezi J, Purdie K, Proby C, Harwood C, Lucas S, Downing R, Quint WG, Newton R. Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: a case-control study in Uganda. Infectious agents and cancer 2008;3:12.
19. Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SCG. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. British Journal of Ophthalmology 2002;86(6):640-5.
20. Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Pe'er J, Savir H, et al.Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 1997;104(12):2085-93.
21. Goldberg JR, Becker SC, Rosenbaum HD. Gamma radiation in the treatment of squamous cell carcinoma of the limbus. American Journal of Ophthalmology 1963;55:811-5.
22. Gunduz K, Ucakhan OO, Kanpolat A, Gunalp I. Non-preserved human amniotic membrane transplantation for conjunctival reconstruction after excision of extensive ocular surface neoplasia. Eye 2005;20(3):351-7.
23. Guthoff R, Marx A, Stroebel P. No evidence for a pathogenic role of human papillomavirus infection in ocular surface squamous neoplasia in Germany. Current Eye Research 2009;34:666-71.
24. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000;19(3):348-52.
25. Kaji Y, Hiraoka T, Oshika T. Vital staining of squamous cell carcinoma of the conjunctiva using toluidine blue. Acta Ophthalmologica Scandinavica 2006;84(6):825-6.
26. Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology 2001;108(6):1093-8.
27. Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG editor(s). Basic and clinical pharmacology. 9th Edition. Boston: McGraw Hill, 2004:931-57.
28. Lee GA, Hirst LW. Retrospective study of ocular surface squamous neoplasia. Australian and New Zealand Journal of Ophthalmology 1997;25(4):269-76.
29. Macarez R, Bossis S, Robinet A, Le Callonnec A, Charlin JF, Colin J. Conjunctival epithelial neoplasias in organ transplant patients receiving cyclosporine therapy. Cornea 1999;18(4):495-7.
30. Mahomed A, Chetty R. Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Archives of Ophthalmology 2002;120(5):554-8.
31. Margo CE, Harman LE, Mulla ZD. The reliability of clinical methods in ophthalmology. Survey of Ophthalmology 2002;47(4):375-86.
32. McKelvie PA, Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. British Journal of Ophthalmology 2001;85(9):1115-9.
33. McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. British Journal of Ophthalmology 2002;86(2):168-73.
34. Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. British Journal of Ophthalmology 2000;84(3):268-72.
35. Moubayed P, Mwakyoma H, Schneider DT. High frequency of Human Papillomavirus 6/11, 16, and 18 infections in precancerous lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania. American Journal of Clinical Pathology 2004;122:938-43.
36. Nadjari B, Kersten A, Ross B, Motherby H, Krallmann R, Sundmacher R, et al.Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva. Analytical and Quantitative Cytology and Histology 1999;21(5):387-96.
37. Nakamura Y, Mashima Y, Kameyama K, Mukai M, Oguchi Y. Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation and polymerase chain reaction. British Journal of Ophthalmology 1997;81(4):308-13.
38. Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, Beral V, et al.The epidemiology of conjunctival squamous cell carcinoma in Uganda. British Journal of Cancer 2002;87(3):301-8.
39. Ng J, Coroneo MT, Wakefield D, Di Girolamo N. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia. Investigative Ophthalmology & Visual Science 2008;49:5295-5306.
40. U.S. National Institutes of Health. Information on clinical trials and human research studies. www.clinicaltrials.gov (accessed 10 February 2012).
41. Osahon AI, Ukponmwan CU, Uhunmwangho OM. Prevalence of HIV seropositivity among patients with squamous cell carcinoma of the conjunctiva. Asian Pacific Journal of Tropical Biomedicine 2011;1(2):150-53.
42. Peksayar G, Soyturk MK, Demiryont M. Long-term results of cryotherapy on malignant epithelial tumours of the conjunctiva. American Journal of Ophthalmology 1989;107(4):337-49.
43. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al.Levels of evidence and grades of recommendation. www.cebm.net/levels_of_evidence.asp (accessed 14 June 2006).
44. Pola EC, Masanganise R, Rusakaniko S. The trend of ocular surface squamous neoplasia among ocular surface tumour biopsies submitted for histology from Sekuru Kaguvi Eye Unit, Harare between 1996 and 2000. Central African Journal of Medicine 2003;49:1-4.
45. Poole TR. Conjunctival squamous cell carcinoma in Tanzania. British Journal of Ophthalmology 1999;83(2):177-9.
46. Porges Y, Groisman GM. Prevalence of HIV with conjunctival squamous cell neoplasia in an African provincial hospital. Cornea 2003;22(1):1-4.
47. Safrin S. Antiviral agents. In: Katzung BG editor(s). Basic and clinical pharmacology. 9th Edition. Boston: McGraw Hill, 2004:801-27.
48. Sen S, Sharma A, Panda A. Immunohistochemical localization of human papilloma virus in conjunctival neoplasias: a retrospective study. Indian Journal of Ophthalmology 2007;55:361-3.
49. Sherman MD, Feldman KA, Farahmand SM, Margolis TP. Treatment of conjunctival squamous cell carcinoma with topical cidofovir. American Journal of Ophthalmology 2002;134(3):432-3.
50. Shields JA, Shields CL, Suvarnamani C, Tantisira M, Shah P. Orbital exenteration with eyelid sparing: indications, technique and results. Ophthalmic surgery 1991;22(5):292-7.
51. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumours: The 1994 Lynn B. McMahan Lecture. Archives of Ophthalmology 1997;115(6):808-15.
52. Shields JA, Shields CL. Tumors of the conjunctiva and cornea. In: McLeod SD editor In: Tasman W, Jaeger EA editor(s). Duane's clinical ophthalmology CD-ROM. Revised 2004. Vol. 4, Philadelphia: Lippincott William and Wilkins, 2004:Chapter 10.
53. Sudesh S, Rapuano CJ, Cohen EJ, Eagle RC Jr, Laibson PR. Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea 2000;19(3):278-83.
54. Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival neoplasia. Ophthalmology 1997;104(3):485-92.
55. Tornesello ML, Duraturo ML, Waddell KM, Biryahwaho B, Downing R, Balinandi S, et al.Evaluating the role of human papillomaviruses in conjunctival neoplasia. British Journal of Cancer 2006;94(3):446-9.
56. Tunc M, Char DH, Crawford B, Miller T. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. British Journal of Ophthalmology 1999;83(1):98-103.
57. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010. http://www.unaids.org/globalreport/global_report.htm 2010.
58. Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, Liomba G. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. British Journal of Ophthalmology 1996;80(6):503-8.
59. WHO ICTRP. WHO International Clinical Trials Registry Platform. www.who.int/ictrp/ (accessed on 10 February 2012).
60. Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walker KA. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 2000;107(12):2190-5.